The sterility of circulating human blood has been questioned. A circulating blood microbiome in healthy and disease states have been reported in adults associated with systemic inflammation but no such data exists in preterm neonates. Our preliminary data shows that the blood of neonates whose blood cultures were negative and who were considered non-infected, contained microbial DNA that can be characterized into distinct phylogenetic groups. The hypothesis of the proposed research is that the microbial diversity and composition of the circulating blood microbiome in preterm neonates is altered in infective states such as sepsis, and the blood microbiome contributes to systemic inflammation. We will use a holistic, multi- omics approach to test our hypothesis using 2 specific aims.
In specific aim 1, we will determine the microbial diversity and composition of the circulating blood microbiome (bacterial, fungal and viral) in healthy preterm neonates and compare it with infants with culture-positive and culture-negative sepsis. In our second specific aim, we propose to determine the association of the blood microbiome signatures with systemic inflammation and neonatal outcomes. Our study will enroll a total of 60 preterm neonates; 20 with culture-proven sepsis, 20 neonates who do not have sepsis but have blood cultures drawn for symptoms of sepsis and were negative and 20 asymptomatic preterm neonates. The bacterial microbiome will be evaluated by metagenomic whole shotgun sequencing, fungal microbiome (mycobiome) by targeting ITS2 region and virome by established methods. Stool and skin swabs will be evaluated by 16S rDNA sequencing and cytokines profiles in the serum will be evaluated. We will use multivariable analyses to correlate microbial load, diversity and composition and cytokine profiles to clinical outcomes. Our proposal is innovative in that the presence of the blood microbiome, it?s association with inflammation and outcomes in the neonatal population has not been reported and will challenge the current paradigm of sterile blood in healthy neonates. The significance of the proposed research is that we will underpin the pathophysiology of ?culture-negative sepsis? that is often associated with overuse of antibiotics. By utilizing our state-of-the-science technology, analysis tools and technical expertise available at the Texas Medical Center, we are poised to advance our knowledge on the blood microbiome and inflammatory injury, that may lead to innovative anti-inflammatory therapy in vulnerable preterm infants.

Public Health Relevance

The clinical implications and characteristics of a circulating blood microbiome in preterm infant are not known. This research proposal will test the novel hypothesis that inflammation associated with blood microbiome (bacterial, fungal and viral) is responsible tissue and organ injury in neonatal sepsis in preterm infants, utilizing the ?state of the art? core facilities at Baylor College of Medicine. The insight gained from this research will significantly decrease antibiotic overuse associated with culture-negative sepsis and will lead to innovative anti- inflammatory strategies against sepsis in preterm infants.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Small Research Grants (R03)
Project #
5R03HD098482-02
Application #
10119311
Study Section
National Institute of Child Health and Human Development Initial Review Group (CHHD)
Program Officer
Ilekis, John V
Project Start
2020-03-04
Project End
2022-02-28
Budget Start
2021-03-01
Budget End
2022-02-28
Support Year
2
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Pediatrics
Type
Schools of Medicine
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030